NFASC rs72820274: Daytime Alertness Genetics Explained
The single nucleotide polymorphism rs72820274 is a genetic variant mapped to the neurofascin (NFASC) gene region. In multivariate genome-wide association modeling of sleep health, this locus was identified as significantly modulating daytime alertness patterns. Understanding this variant offers insight into the neurobiological underpinnings of wakefulness without serving as a direct clinical diagnosis.
What each genotype means
| Genotype | What the research suggests | Reading |
|---|---|---|
| Major Allele Homozygote (Common Genotype) | This genotype consists of two copies of the common baseline allele at rs72820274. In population studies, it represents the standard reference profile for daytime alertness modeling within the NFASC locus. It is not associated with altered baseline vigilance scores. | Informational |
| Heterozygote (Carrier Genotype) | Carriers possess one copy of the minor allele (~0.08 frequency in Europeans) and one major allele. In multivariate sleep modeling, this genotype is associated with subtle statistical modulations in daytime alertness measures. It reflects an incremental polygenic contribution rather than a noticeable personal deficit. | Informational |
| Minor Allele Homozygote (Rare Genotype) | Carrying two copies of the minor allele is uncommon in the general population due to low allele frequency. Individuals with this genotype exhibit the maximum statistical shift attributed to this specific single locus in alertness models. Because overall alertness is governed by many genes and lifestyle factors, its practical impact on day-to-day energy remains modest. | Higher attention |
Genomic Location and the NFASC Locus
The variant rs72820274 is located within the genomic boundaries of the NFASC gene on chromosome 1. As indexed in genetic repositories such as [dbSNP](https://www.ncbi.nlm.nih.gov/snp/rs72820274), this single nucleotide polymorphism reflects an inherited variation in the human DNA sequence. The NFASC gene encodes neurofascin, an immunoglobulin superfamily cell adhesion molecule crucial for the organization of the nervous system. Specifically, neurofascin plays an essential structural and functional role at the nodes of Ranvier and axon initial segments, which coordinate the rapid propagation of electrical action potentials along myelinated axons in both central and peripheral neural circuits.
Scientific Evidence from Sleep Health GWAS
In large-scale multivariate investigations of human sleep architecture, rs72820274 emerged as a significant locus modulating sleep-wake phenotypes, as described in [multivariate sleep health research](https://pmc.ncbi.nlm.nih.gov/articles/PMC10851865/). Using structural equation modeling methods such as Genomic SEM to evaluate composite domains of sleep health, researchers identified rs72820274 as an independent locus linked to the daytime alertness domain. While classical single-indicator GWAS studies focus on isolated complaints like subjective daytime sleepiness or nap duration, multivariate framework modeling captures underlying genetic latent factors. The statistical evidence linking rs72820274 to alertness is considered moderate, reflecting robust discovery in multivariate models that warrants further functional replication across diverse cohorts.
Biological Mechanisms in Sleep and Alertness
The physiological connection between the NFASC locus and daytime alertness relates to neural communication efficiency. Neurofascin proteins maintain the clustering of voltage-gated sodium channels along axons, ensuring precise and coordinated signal transmission across brain networks. Subcortical arousal pathways and thalamocortical networks heavily depend on sustained, high-fidelity signaling to preserve daytime vigilance and regulate transitions between sleep and waking states. Regulatory variants within or near NFASC may subtly alter gene expression, channel organization, or synaptic stability, slightly nudging an individual's baseline propensity toward daytime tiredness or sustained wakefulness.
Population Frequency and Diversity
Allele frequencies for rs72820274 vary across different ancestral backgrounds. In populations of European descent, the minor allele demonstrates a frequency of approximately 0.08, meaning roughly 15% of individuals carry at least one copy of the less common allele. Data across other world populations remain less detailed in standard catalogs, emphasizing the ongoing need for diverse ancestry representation in sleep genomics research. Because the minor allele is present in a minority of individuals, comparative association strengths may differ depending on linkage disequilibrium patterns and genetic background in non-European groups.
Clinical Meaning and Practical Takeaways
Possessing a specific genotype at rs72820274 is not a diagnosis of a sleep disorder, such as narcolepsy or obstructive sleep apnea, nor does it predict definitive insomnia or fatigue. Complex behavioral traits like daytime alertness are polygenic, shaped by thousands of minor genetic variants acting alongside environmental factors such as work schedules, sleep hygiene, caffeine intake, and physical activity. Genetic test results detailing this locus describe statistical baseline tendencies across populations. Individuals experiencing chronic daytime sleepiness, unrefreshing sleep, or cognitive fatigue should consult a qualified healthcare provider for clinical evaluation rather than relying on genetic markers.
How common is this variant?
The minor allele at rs72820274 has a frequency of approximately 0.08 in European populations, making homozygous carriers relatively uncommon. Broader global population frequencies remain sparsely documented, underscoring the need for further diverse genomic studies.
Frequently asked questions
Does having the rs72820274 variant mean I will have chronic daytime fatigue?
No, rs72820274 is not a causative or deterministic genetic marker for fatigue or sleep disorders. It was identified in population-level modeling as contributing a small statistical effect to composite daytime alertness traits. Daily energy levels depend overwhelmingly on overall sleep duration, sleep quality, stress levels, medical conditions, and daily habits.
What is the function of the NFASC gene?
The NFASC gene codes for neurofascin, an essential cell adhesion molecule in the nervous system. It helps anchor ion channels at axonal nodes of Ranvier, allowing electrical impulses to travel quickly and accurately between brain cells.
Can a genetic test for rs72820274 replace a clinical sleep study?
No, commercial or direct-to-consumer genetic findings for rs72820274 cannot evaluate, diagnose, or replace clinical sleep assessments. Conditions such as sleep apnea, restless legs syndrome, and insomnia require direct evaluation by a physician using validated clinical criteria and objective sleep studies.
Are there medications targeting the rs72820274 variant?
There are currently no prescription or over-the-counter medications designed to target rs72820274. Anyone considering medications or supplements to manage daytime alertness or nighttime sleep should discuss treatment choices with a doctor or pharmacist.
Sources & further reading
Educational information only, last refreshed 9/4/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs72820274?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29